Scribe Therapeutics, Inc. (SCTX)

16.00 +0.52 (+3.36%) USD  |  NASDAQ  |  Nov 06, 10:21
More

Scribe Therapeutics Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for SCTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
Date Value
June 30, 2025 --
March 31, 2025 --

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Veracyte, Inc. Upgrade
Cypherpunk Technologies, Inc. Upgrade
Nurix Therapeutics, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
Revenue (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Gross Profit Margin (Quarterly) Upgrade
Profit Margin (Quarterly) Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade